Analysts estimate Stericycle, Inc. (NASDAQ:SRCL) PT at $62.25

Stericycle, Inc. (NASDAQ:SRCL – Get Free Report) has received a consensus recommendation of ‘Hold’ from the five analysts currently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the company. The average one-year price target among brokers who updated their coverage of the stock in the past year is $60.80.

Several research analysts have recently commented on SRCL stock. Truist Financial raised their target price on Stericycle from $50.00 to $57.00 and gave the stock a “hold” rating in a report on Thursday, February 29. Robert W. Baird lowered his price target on Stericycle from $62.00 to $55.00 and set a “neutral” rating on the stock in a report on Friday. Royal Bank of Canada reiterated an “outperform” rating and set a $69.00 price target on shares of Stericycle in a report on Thursday, March 7. StockNews.com downgraded Stericycle from a “buy” rating to a “hold” rating in a report on Tuesday, April 2nd. Finally, Stifel Nicolaus raised their price objective on Stericycle from $70.00 to $75.00 and gave the stock a “buy” rating in a research report on Thursday, February 29.

Read our latest research report on SRCL

Stericycle trading drops 0.4%

SRCL shares opened at $46.31 on Friday. The stock’s fifty-day moving average is $51.35 and its two-hundred-day moving average is $48.24. The company has a debt-to-equity ratio of 0.55, a quick ratio of 0.94 and a current ratio of 1.11. The company has a market cap of $4.30 billion, a price-to-earnings ratio of -210.50, a PEG ratio of 2.49, and a beta of 1.09. Stericycle has a fifty-two week low of $37.78 and a fifty-two week high of $57.06.

Stericycle (NASDAQ:SRCL – Get Free Report) last reported its quarterly earnings data on Thursday, April 25. The business services provider reported $0.57 earnings per share for the quarter, beating analysts’ consensus estimates of $0.54 by $0.03. Stericycle had a positive return on equity of 7.31% and a negative net margin of 0.74%. The company had revenue of $664.90 million for the quarter, compared to analyst estimates of $676.42 million. In the same quarter last year, the company posted earnings per share of $0.49. The company’s revenue fell 2.8% year over year this quarter. Research analysts expect Stericycle to post earnings per share of 2.32 for the current fiscal year.

Institutional trading in Stericycle

Hedge funds and other institutional investors have recently changed their positions in the company. Principal Securities Inc. acquired a new position in Stericycle in the 4th quarter worth approximately $41,000. GAMMA Investing LLC grew its position in Stericycle by 170.9% in the first quarter. GAMMA Investing LLC now owns 818 shares of the business services provider’s stock valued at $43,000 after acquiring an additional 516 shares in the last quarter. TFO Wealth Partners LLC grew its position in Stericycle by 22,325.0% in the 4th quarter. TFO Wealth Partners LLC now owns 897 shares of the business services provider’s stock valued at $44,000 after acquiring an additional 893 shares in the last quarter. Exchange Traded Concepts LLC grew its position in Stericycle by 87.5% in the third quarter. Exchange Traded Concepts LLC now owns 1,001 shares of the business services provider’s stock valued at $45,000 after acquiring an additional 467 shares in the last quarter. Finally, Ramirez acquired Asset Management Inc. a new position in Stericycle worth approximately $45,000 in the third quarter. 98.82% of the shares are held by institutional investors and hedge funds.

About Stericycle

(Get a free report

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe and internationally. The company provides regulated waste and compliance services including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste and integrated waste stream solutions; specialist services such as MedDrop medicine collection kiosks, safe community solutions, SafeDrop sharps mailback solutions and airport and marine waste services; retail services for medical supplies, including sharps and disposable biohazard waste containers, infection control supplies, and medication mail sealing and return; and compliance solutions, including Steri-Safe compliance solutions.

read more

Get daily news and reviews for Stericycle – Enter your email address below to receive a daily digest of the latest news and analyst ratings for Stericycle and related companies with MarketBeat.com’s FREE daily email newsletter.